| Period Ending: |
LTM
(Last Twelve Months) |
2021 12-31 |
|---|---|---|
| Report Filing | 2022-11-10 | 2022-03-31 |
| Revenue | 0 | 0 |
| Cost of Revenue | 0.617 | 0 |
| Gross Profit | -0.617 | 0 |
| Operating Expenses | -2.56 | 4.41 |
| Research & Development | 0 | 0 |
| Selling, General and Administrative | 0 | 0 |
| Other Operating Expenses | -2.56 | 4.41 |
| Operating Income | 1.94 | -4.41 |
| Net Non-Operating Interest | 7.21 | 7.21 |
| Interest Income | 0 | 0 |
| Interest Expense | -7.21 | -7.21 |
| Equity & Other Income/(Expense) | 0 | 0 |
| Income Before Tax | 9.15 | 2.8 |
| Income Tax Expense | -3.71 | -7.21 |
| Income Attributable to Non-Controlling Interest | -2.35 | 0 |
| Net Income | 15.2 | 10.01 |
| Depreciation and Amortization | 8.18 | 7.21 |
| EBITDA | 10.12 | 2.8 |
| Earnings Per Share (EPS) | 0.761 | 0.46 |
| Diluted Earnings Per Share | 0.761 | 0.46 |
| Weighted Average Shares Outstanding | 17.25 | 21.56 |
| Diluted Weighted Average Shares Outstanding | 17.25 | 21.56 |
